Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. FDX
2. CBRS
3. HTZ
4. KBH
5. HON
6. TTWO
7. USO
8. MRK
9. QCOM
10. SPY

Go back to Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
(NASDAQ: EDSA) Delayed: 7.56 -0.08 (1.05%)
Previous Close $7.64    52 Week High $ 
Open $7.35    52 Week Low $ 
Day High $7.72    P/E N/A 
Day Low $7.31    EPS $ 
Volume 29,568